Arctop
Company

Last deal

$10M

Amount

Series A

Stage

10.10.2023

Date

3

all rounds

$15M

Total amount

General

About Company
Arctop provides neural interface technology that analyzes brain signals and produces an accurate measure of the mind in real-time.

Industry

Sector :

Subsector :

Keywords :

founded date

15.06.2016

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Arctop's patented technology Neuos™ is used by biometric authentication, gaming, neurological health, education and entertainment applications that connect consumers and enterprise customers daily to their own brain activity and enable them to unlock its potential. The company's system enables developers to build applications that understand humans in real-time and deliver outstanding experience and technology allows them to respond to human feelings and attention in the moment, facilitating precise, effective digital interactions and new dimensions of personalization and recommendation.
Contacts

Social url